
Welcome
Welcome to the website of the CellCOM Research Group. Our group is a translational and clinical research group within the Center for Research in Nanomaterials and Biomedicine (CINBIO). Our approaches combine in vitro, ex vivo and in vivo models to conduct pre-clinical studies in age-related diseases and cancer. Our group is a multidisciplinary team that includes basic scientists (predoctoral, postdoctoral fellows and technicians) and clinical researchers such as pathologists, dermatologists, radiologists and surgeons.
Our aims are to understand the physiopathology of connexin-linked diseases (cancer, inflammation, tissue degeneration), to design molecules and new drugs that modulate the activity of specific targets and to identify novel markers of disease prevention, diagnosis and disease management.
We are focused on understanding the role of connexins and pannexins in osteoarthritis, skin wound healing in oncological patients, metastasis and resistance to targeted cancer therapies and immunotherapies. Our final goal is to identify effective therapeutic targets to design specific and successful therapeutic approaches to treat these disorders.
Follow us on Twitter to stay updated on news
Latest news
Publication in the main science divulgation journal in Spain.
March 2018 Publication in the main science divulgation journal in Spain.…
Connexin and pannexin channels in inflammation and cancer
Sept 2018 Science Xpression 2018 Sixth edition of Science Xpression…
New results published in BBA-Biomembranes
Sept 2018 Intercellular communication via gap junction channels between chondrocytes…
SEBBM congress in Santander
Sept 2018 We have actively participated in the SEBBM congress in…
Postdoctoral Research Opportunities
March 2017 Postdoctoral Researcher: MRC Harwell, Oxforshire, UK We are seeking…
Eppendorf Scientific Prize – SEBBM, FEBS3 AWARDS
Oct 2017 Best scientific image of the year, FEBS3 AWARDS…